ACE2 and viral infectious disease: SARS-CoV-2 uses spike glycoproteins to bind to angiotensin-converting enzyme 2 (ACE2); disrupting this SARS-CoV-2-ACE2 complex is potentially beneficial in preventing viral infection [17].